Translumina GmbH, Germany is a development and manufacturing specialist of medical devices being used in interventional cardiology and radiology. Our flagship products, YUKON® Choice PC and YUKON® Chrome PC, represent the 3rd generation metallic drug eluting stents. Uniquely, these DES products favorably make use of the synergy of combining drug - biodegradable polymer been coated on the abluminal microporous stent surface, thus creating optimum drug release kinetics (Sirolimus). Customers benefit from a wide range of stent sizes from Φ 2.0 mm to Φ 4.0 mm and lengths from 8 mm to 40 mm. YUKON® Choice PC passed very successfully randomized clinical trials with 10 years follow-up (2603 patients in ISAR test 4). YUKON® Choice PC, again and repeatedly has been referenced along with US FDA approved products in the European Society of Cardiology Guidelines, latest in the ESC guidelines for myocardial revascularization 2018 due to its strength of clinical data. YUKON® Choice PC has published data in index journals like Journal of American College of Cardiology, European Heart Journal, Biomaterials, Circulation and EuroIntervention. Our other products encompass a wide range of bare metal stents and coronary angioplasty balloons. Translumina GmbH – trust is what counts!
Translumina GmbH, Germany is a development and manufacturing specialist of medical devices being used in interventional cardiology and radiology. Our flagship products, YUKON® Choice PC and YUKON® Chrome PC, represent the 3rd generation metallic drug eluting stents. Uniquely, these DES products favorably make use of the synergy of combining drug - biodegradable polymer been coated on the abluminal microporous stent surface, thus creating optimum drug release kinetics (Sirolimus). Customers benefit from a wide range of stent sizes from Φ 2.0 mm to Φ 4.0 mm and lengths from 8 mm to 40 mm. YUKON® Choice PC passed very successfully randomized clinical trials with 10 years follow-up (2603 patients in ISAR test 4). YUKON® Choice PC, again and repeatedly has been referenced along with US FDA approved products in the European Society of Cardiology Guidelines, latest in the ESC guidelines for myocardial revascularization 2018 due to its strength of clinical data. YUKON® Choice PC has published data in index journals like Journal of American College of Cardiology, European Heart Journal, Biomaterials, Circulation and EuroIntervention. Our other products encompass a wide range of bare metal stents and coronary angioplasty balloons. Translumina GmbH – trust is what counts!